Results 101 to 110 of about 29,994 (144)

Single-cell omics in investigating the effect of CAFs with KRAS overexpression on the malignant progression of anaplastic thyroid cancer. [PDF]

J Chin Med Assoc
Sun H, Chen Q, Li G, Chen M, Dai J, Yan M.   +5 more
europepmc   +1 more source

Heterobifunctional proteomimetic polymers for targeted degradation of MYC and KRAS. [PDF]

Nat Commun
Wang MM, Truica MI, Gattis BS, Oktawiec J, Sagar V, Basu AA, Bertin PA, Zhang X, Abdulkadir SA, Gianneschi NC.   +9 more
europepmc   +1 more source

Emerging Therapeutic Landscapes for KRAS-Mutant Pancreatic Ductal Adenocarcinoma: Beyond the "Undruggable" Paradigm. [PDF]

Turk J Gastroenterol
Li W, Lin X, Liu P, Zhang J, Liu C.
europepmc   +1 more source

Nerve growth factor (NGF) [PDF]

, 1989
Azzi, Angelo, Borasio, Gian Domenico, Drahota, S., Heumann, R., Lindholm, D., Papa, S., Thoenen, Hans   +6 more
core  

Exportin 1 as a Therapeutic Target to Overcome Drug Resistance in Lung Cancer. [PDF]

Cells
Di Marco MV, Gasparetto A, Chiarle R, Voena C.   +3 more
europepmc   +1 more source

Dual Inhibitors of KRASG12D and HSP90 Are Effective against KRASG12D Inhibitor Resistance. [PDF]

Mol Cancer Ther
Pulido I, Gunder LC, Ying C, Wang Y, Dai Y, Yang Z, Rahnama A, Li J, Sun Y, Liu C, Zhou H, Wang G, Foley KP, Abdelhady K, Massad MG, Prince TL, Papautsky I, Ying W, Shimamura T.   +18 more
europepmc   +1 more source

A novel anticancer natural product SP09 selectively targets KRAS-mutant NSCLC through LKB1/AMPK/mTOR modulation: implications for novel therapeutic development. [PDF]

Anticancer Drugs
Yue P, Hon C, Zhao X, Ali F, Sun J, Kou J.   +5 more
europepmc   +1 more source

Clinical Significance and Potential Molecular Mechanisms of Angiotensin-Converting Enzyme 2 in Colorectal Cancer. [PDF]

World J Oncol
Zeng DT, Yang L, Wen JY, Wu KJ, Chen GQ, Li ZY, Ling JW, Huang BB, Xie YY, Dong YY, Fang YY, Wei DM, Chen G, Shi L, Huang WJ.   +14 more
europepmc   +1 more source

Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma. [PDF]

Int J Mol Sci
Soloveva M, Solovev M, Yakutik I, Biderman B, Nikulina E, Risinskaya N, Obukhova T, Gladysheva M, Kovrigina A, Chabaeva Y, Kulikov S, Sudarikov A, Mendeleeva L.   +12 more
europepmc   +1 more source

Unlocking <i>KRAS</i>: Navigating Its Molecular Biology and Treatment Landscape Among Gastrointestinal Malignancies. [PDF]

Curr Oncol
Frisch A, Martin E, Cannon T, Wadlow R, Raghavan S, Sen T, Karim NA.   +6 more
europepmc   +1 more source